Clinical Trial Detail

NCT ID NCT03224819
Title Study of AMG 673 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications

acute myeloid leukemia

Therapies

AMG 673

Age Groups: adult senior

No variant requirements are available.